147 related articles for article (PubMed ID: 10999809)
21. Decreased muscle capillary permeability surface area in type 2 diabetic subjects.
Gudbjörnsdóttir S; Sjöstrand M; Strindberg L; Lönnroth P
J Clin Endocrinol Metab; 2005 Feb; 90(2):1078-82. PubMed ID: 15536160
[TBL] [Abstract][Full Text] [Related]
22. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
[TBL] [Abstract][Full Text] [Related]
23. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm.
Clemson B; Gaul L; Gubin SS; Campsey DM; McConville J; Nussberger J; Zelis R
J Clin Invest; 1994 Feb; 93(2):684-91. PubMed ID: 8113403
[TBL] [Abstract][Full Text] [Related]
24. Insulin-mediated increase in blood flow is impaired in the elderly.
Meneilly GS; Elliot T; Bryer-Ash M; Floras JS
J Clin Endocrinol Metab; 1995 Jun; 80(6):1899-903. PubMed ID: 7775638
[TBL] [Abstract][Full Text] [Related]
25. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson EA; Hoffman RP; Balon TW; Sinkey CA; Mark AL
J Clin Invest; 1991 Jun; 87(6):2246-52. PubMed ID: 2040704
[TBL] [Abstract][Full Text] [Related]
26. Decreased adrenergic tone in acromegaly: evidence from direct recording of muscle sympathetic nerve activity.
Seravalle G; Carzaniga C; Attanasio R; Grassi G; Lonati L; Facchini C; Cozzi R; Fatti LM; Montini M; Vitale G; Sciortino G; Damanti S; Brambilla G; Cavagnini F; Mancia G; Scacchi M
Clin Endocrinol (Oxf); 2012 Aug; 77(2):262-7. PubMed ID: 22233452
[TBL] [Abstract][Full Text] [Related]
27. Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease.
Seravalle G; Carzaniga C; Sciortino G; Attanasio R; Fatti LM; Cozzi R; Montini M; Vitale G; Brambilla G; Cavagnini F; Mancia G; Grassi G; Scacchi M
Clin Exp Pharmacol Physiol; 2013 May; 40(5):333-7. PubMed ID: 23528035
[TBL] [Abstract][Full Text] [Related]
28. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans.
Anderson EA; Balon TW; Hoffman RP; Sinkey CA; Mark AL
Hypertension; 1992 Jun; 19(6 Pt 2):621-7. PubMed ID: 1592458
[TBL] [Abstract][Full Text] [Related]
29. Effect of age on insulin stimulation of sympathetic nervous system activity in man.
Minaker KL; Rowe JW; Young JB; Sparrow D; Pallotta JA; Landsberg L
Metabolism; 1982 Dec; 31(12):1181-4. PubMed ID: 6755163
[TBL] [Abstract][Full Text] [Related]
30. Dietary sodium intake modulates systemic but not forearm norepinephrine release.
Stein CM; Nelson R; Brown M; He H; Wood M; Wood AJ
Clin Pharmacol Ther; 1995 Oct; 58(4):425-33. PubMed ID: 7586935
[TBL] [Abstract][Full Text] [Related]
31. Forearm vasoconstrictor response in uncomplicated type 1 diabetes mellitus.
van Gurp PJ; Willemsen JJ; Lenders JW; Ross HA; Sweep CG; Smits P; Tack CJ
Eur J Clin Invest; 2006 Oct; 36(10):674-81. PubMed ID: 16968462
[TBL] [Abstract][Full Text] [Related]
32. Direct neurohumoral evidence for isolated sympathetic nervous system activation to skeletal muscle in response to cardiopulmonary baroreceptor unloading.
Baily RG; Prophet SA; Shenberger JS; Zelis R; Sinoway LI
Circ Res; 1990 Jun; 66(6):1720-8. PubMed ID: 2344670
[TBL] [Abstract][Full Text] [Related]
33. A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Karapanagiotidis S; Wong C; Richards K; Marusic P; Dixon JB; Schlaich MP; Lambert EA
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1701-7. PubMed ID: 24937541
[TBL] [Abstract][Full Text] [Related]
34. Effect of 10 days of bedrest on metabolic and vascular insulin action: a study in individuals at risk for type 2 diabetes.
Sonne MP; Alibegovic AC; Højbjerre L; Vaag A; Stallknecht B; Dela F
J Appl Physiol (1985); 2010 Apr; 108(4):830-7. PubMed ID: 20110547
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
Møller N; Bagger JP; Schmitz O; Jørgensen JO; Ovesen P; Møller J; Alberti KG; Orskov H
J Clin Endocrinol Metab; 1995 Jun; 80(6):1789-93. PubMed ID: 7775624
[TBL] [Abstract][Full Text] [Related]
36. Insulin stimulates epinephrine release under euglycemic conditions in humans.
Tack CJ; Lenders JW; Willemsen JJ; van Druten JA; Thien T; Lutterman JA; Smits P
Metabolism; 1998 Mar; 47(3):243-9. PubMed ID: 9500557
[TBL] [Abstract][Full Text] [Related]
37. N(G)-monomethyl-L-arginine alters insulin-mediated calf blood flow but not glucose disposal in the elderly.
Meneilly GS; Elliott T; Battistini B; Floras JS
Metabolism; 2001 Mar; 50(3):306-10. PubMed ID: 11230783
[TBL] [Abstract][Full Text] [Related]
38. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide.
Ahrén B; Veith RC; Paquette TL; Taborsky GJ
Endocrinology; 1987 Jul; 121(1):332-9. PubMed ID: 2885175
[TBL] [Abstract][Full Text] [Related]
39. Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.
Natali A; Bonadonna R; Santoro D; Galvan AQ; Baldi S; Frascerra S; Palombo C; Ghione S; Ferrannini E
J Clin Invest; 1994 Oct; 94(4):1570-6. PubMed ID: 7929833
[TBL] [Abstract][Full Text] [Related]
40. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
Chang PC; Kriek E; van Brummelen P
J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
